PPARD and cholangiocarcinoma: Overexpression of NM23-H2 in cholangiocarcinoma cells downregulated PPARβ/δ expression, impedes PPARβ/δ promoter activity and diminishes GW501516 induced cholangiocarcinoma cell proliferation.